Antipsychotics-containing regimen as an alternative to standard antiemetics for delayed nausea induced by highly emetogenic chemotherapy

Journal of Clinical Oncology

Volumn 31, Issue 10, 2013, Pages 1377-1378

  Ishiguro, Hiroshi ^a   Kawaguchi, Kosuke ^a   Nishimura, Tomomi ^a,b   Toi, Masakazu ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; OLANZAPINE; PALONOSETRON; PROCHLORPERAZINE;

ABSENCE OF SIDE EFFECTS; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; HUMAN; LETTER; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; NAUSEA;

EID: 84876088496     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.2951     Document Type: Letter

References (4)

1. Roscoe JA, Heckler CE, Morrow GR, et al: Prevention of delayed nausea: A University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol 30:3389-3395, 2012
2. Carr BI, Bertrand M, Browning S, et al: A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: A prospective, randomized, double-blind study. J Clin Oncol 3:1127-1132, 1985 (Pubitemid 15004835)
3. Bymaster FP, Falcone JF, Bauzon D, et al: Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. Eur J Pharmacol 430:341-349, 2001 (Pubitemid 33050060)
4. Navari RM, Gray SE, Kerr AC: Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A randomized phase III trial. J Support Oncol 9:188-195, 2011